Global MicroRNA Market Poised for Rapid Growth, Expected to Reach USD 15.5 Billion by 2033

The global microRNA (miRNA) market has witnessed significant growth, with sales reaching US$ 1.2 billion in 2023. The market is projected to expand at an impressive CAGR of 29.4% from 2023 to 2033, ultimately reaching US$ 15.5 billion by 2033. MicroRNAs, small non-coding RNA molecules found in animals, plants, and viruses, play a crucial role in gene regulation. Their increasing relevance in diagnosing and treating chronic illnesses like liver disease, coronary heart disease, and cancer is driving substantial demand within the healthcare sector. With technological advancements and expanding clinical applications, the microRNA market is poised for exponential growth over the next decade.

Dive into the most impactful insights from our Report in this sample

Key Drivers and Industry Trends

One of the major factors fueling the expansion of the microRNA market is the growing application of microRNA in clinical and preclinical research. MicroRNAs serve as biomarkers for diseases, modulators of drug resistance, and therapeutic agents, making them indispensable in modern medicine. The increasing number of clinical trials investigating microRNA-based therapies is a key driver of market demand. For instance, a medicinal trial in 2016 evaluated TargomiRs, a microRNA mimic-based therapy for thoracic cancer, demonstrating the immense potential of microRNA-based treatments.

Moreover, technological advancements are significantly improving microRNA research methodologies. Innovations in expression profiling, gene identification, and validation have accelerated breakthroughs. For example, HTG Molecular Diagnostics, Inc. launched the HTG EdgeSeq mouse microRNA whole transcriptome test, offering comprehensive microRNA expression profiling. The growing number of biotech and pharma firms investing in microRNA-based drugs further underscores the market’s upward trajectory.

Despite this growth, certain factors pose challenges. The safety and toxicity of microRNA-based treatments remain contentious, leading to setbacks in clinical trials. For example, MicroRNA Therapeutics, Inc. terminated its Phase 1 study of MRX34 due to adverse immune-related effects. These hurdles underscore the need for further research and refinement before microRNA therapies can achieve mainstream clinical acceptance.

Regional Outlook and Competitive Landscape

The North American region dominates the microRNA market, primarily due to an increasing number of clinical trials and robust healthcare spending. The U.S., in particular, is expected to reach a market valuation of US$ 6.7 billion by 2033, driven by its strong research infrastructure and growing focus on novel treatments.

Meanwhile, the Asia Pacific region is projected to witness the fastest growth, attributed to a larger patient pool, rising adoption of microRNA-based therapies, and expanding medical tourism. Countries like India, China, and Singapore are at the forefront of this growth, benefiting from government support and research investments.

The competitive landscape is characterized by a mix of global and regional players striving for market dominance. Companies like Merck KGaA, Thermo Fisher Scientific, Horizon Discovery, QIAGEN, and NanoString are leading the charge with innovations in microRNA profiling and functional analysis. Additionally, recent collaborations, acquisitions, and product launches are shaping the market dynamics, allowing firms to expand their global reach.

Market Developments

Recent advancements have paved the way for significant growth in the microRNA market. For example, in March 2021, researchers in China identified blood microRNA as a potential biomarker for hepatic sinusoidal obstruction syndrome using microarray-based profiling. These developments highlight the growing importance of microRNA in disease diagnostics and therapeutics.

Companies are also leveraging computational tools to predict interactions between microRNA and their targets, enhancing research accuracy. The ongoing push toward next-generation sequencing (NGS) and real-time PCR (qPCR) technologies further supports the development of more precise and reliable microRNA-based solutions.

Stay informed with the latest insights—read our full report

Market Segmentation

The microRNA market is segmented across various parameters, including services, products, applications, and end-use industries:

1. By Services:
   • Specimen Types: Whole Blood, Serum, Plasma, FFPE, Fresh Frozen Tissue
   • Service Types: Isolation & Purification, cDNA Synthesis, Profiling & Quantification, Functional Analysis
2. By Products:
   • Instruments
   • Consumables (Fastest-growing segment, projected to grow at a CAGR of 28.5%)
3. By Application:
   • Cancer
   • Infectious Diseases
   • Cardiovascular Disorders
   • Neurological Disorders
   • Immunological Disorders
   • Others
4. By End-Use:
   • Biotechnology & Pharmaceutical Companies
   • Academic & Government Research Institutes
   • Others
5. By Region:
   • North America
   • Latin America
   • Europe
   • Asia Pacific
   • Middle East & Africa

Category-Wise Insights

The microRNA consumables segment is expected to generate the highest revenue due to its frequent use in research applications. In 2022, this segment accounted for over 60% of the total market share. Leading manufacturers such as Thermo Fisher Scientific, Miltenyi Biotec, and NanoString dominate this space, offering high-quality qPCR primers, detection kits, and transfection reagents.

In terms of instruments, real-time PCR (qPCR) continues to be the gold standard for microRNA detection, owing to its high sensitivity and specificity. This method plays a vital role in microRNA profiling, quantification, and functional analysis, making it a key technology in the market.

 About Transparency Market Research

Transparency Market Research, a global market research company registered at Wilmington, Delaware, United States, provides custom research and consulting services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants use proprietary data sources and various tools & techniques to gather and analyses information.

Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.